Literature DB >> 2974909

[The dose of intracoronary urokinase infusion in acute myocardial infarct].

U Tebbe1, K S Herrmann.   

Abstract

In 11 patients with acute myocardial infarction (mean age 52 +/- 6 years) coronary angiography was performed 4.5 +/- 3.6 h after the onset of symptoms. The infarct-related artery was in 7 cases the right coronary artery and in 4 cases the left anterior descending branch of the left coronary artery. The infarct-related artery showed total or subtotal occlusion and no perfusion (Thrombolysis in Myocardial Infarction trial (TIMI) grade 0 or 1). In 7 cases Urokinase was infused intracoronarily at a dosage of 250,000 IU over 30 min, but in only 1 case partial reperfusion was achieved. However, all patients treated with 500,000 IU Urokinase over 30 min or 1 Mill IU over 60 min had successful reperfusion (TIMI grade 2 or 3). Thus, it appears that 500,000 IU up to 1 Mill IU of Urokinase over a period of 30 to 60 min is adequate for intracoronary thrombolysis in patients with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974909     DOI: 10.1007/bf01727669

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  12 in total

1.  Dose of urokinase for intracoronary thrombolysis in patients with acute myocardial infarction.

Authors:  A Ohyagi; K Hirose; Y Watanabe; T Nakai; S Tsujimoto; K Doyama; Y Suzuki; S Okazaki; M Hirai
Journal:  Clin Cardiol       Date:  1987-08       Impact factor: 2.882

2.  Intravenous urokinase in acute myocardial infarction.

Authors:  D G Mathey; J Schofer; F H Sheehan; H Becher; V Tilsner; H T Dodge
Journal:  Am J Cardiol       Date:  1985-04-01       Impact factor: 2.778

Review 3.  Thrombolytic therapy: current status (1).

Authors:  V J Marder; S Sherry
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

4.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

5.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

6.  Coronary thrombolysis with urokinase infusion in acute myocardial infarction: multicenter study in Japan.

Authors:  H Kambara; C Kawai; K Kammatsuse; H Sato; M Nobuyoshi; M Chino; H Miwa; Y Uchida; K Kodama; K Mitsudo
Journal:  Cathet Cardiovasc Diagn       Date:  1985

7.  Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase.

Authors:  S N Tennant; J Dixon; T C Venable; H L Page; A Roach; A B Kaiser; R Frederiksen; L Tacogue; P Kaplan; N S Babu
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

8.  Clinical experience with urokinase in intracoronary thrombolysis.

Authors:  C Cernigliaro; M Sansa; A Campi; A S Bongo; P Rossi
Journal:  Clin Cardiol       Date:  1987-04       Impact factor: 2.882

9.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

10.  A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

Authors: 
Journal:  N Engl J Med       Date:  1986-06-05       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.